Iziguli eziningi ze-thyroid ezithintana nathi noma ezithumela ekhasini le-Facebook Thyroid Support zibuza umbuzo ofanayo: "NgiseSythroid (noma enye imithi ye-levothyroxine efana neLevoxyl) futhi angizizwa kahle. Yini engingayenza? "
Iziguli ze-thyroid yisimo, into yokuqala yokucabanga ngayo ukuthi ungazuza yini noma ungazuza ngokungeziwe kwe-T3 eyengeziwe .
(I-recap emfushane: i-Synthroid, i-Levoxyl nezinye izidakamizwa ze-levothyroxine- futhi okuthiwa i-l-thyroxine, ne-L-T4-ziyizinhlobo zokwenziwa kwehomoni ye-T4. I-T4 yi-hormone yokugcina, futhi kufanele iguqulelwe ibe yi-T3, i-hormone esebenzayo , ukusetshenziselwa amangqamuzana akho. I-Cytomel yezidakamizwa ifomu lobuciko be-T3. Kukhona uhlobo olujwayelekile lwe-Cytomel, kanti abanye abasebenzi basebenza ngokukhululeka okwesikhashana / okugcinwe isikhathi eside T3 ngemithi ekhethiwe evela kuma-pharmacy. I-nature-throid, i- Armor Thyroid iqukethe izinhlobo zemvelo ze-T4, T3 namanye amahomoni wegciwane .)
Manje, emuva kwenkinga yokuthi ungazuzisa yini noma ukungezwa kwe-T3 . Umbuzo wokusebenza uwukuthi: ingabe udokotela wakho uzovuma ngisho nokuxoxa ngalokhu nawe, okungenani uyayichaza? Ayikho impendulo ecacile.
Uma uthi kudokotela, "Ngingazuza yini kwezinye i-T3 ezengeziwe?" impendulo kungenzeka ukuthi ifinyelele kwesinye sezimo ezine ezingenzeka ...
- A. Iyakwenza kucace ukuthi yena akanandaba nenye ingxoxo mayelana ne-T3.
- B. Udokotela ngokuhlonipha uthi, "akuyona into engiyithokozile ngayo. Ngiyaxolisa."
- C. Udokotela ucabanga ngakho, futhi uthi, "kuhle, ake sibheke izinga lakho le-T3 mahhala ukuze sibone ukuthi libukeka kanjani bese wenza isinqumo.
- D. Udokotela uthi, "Ngokuqinisekile lokho kungenzeka. Ake sizame isilinganiso esincane kakhulu se-T3 futhi sibone indlela ozizwa ngayo. Kodwa ake siqiniseke ukuthi akukho okuphikisanayo kuwe ...
Ngokusobala, uma unesiguli sikaDokotela A, ukukhetha okuhle ukuthola udokotela omusha we-thyroid . Ukucela ukuxoxisana ngokuthi kungenzeka ukwelashwa yisicelo esifanele, futhi akufanele nanini kuhlangane nokungahloniphi noma ukuxoshwa. Lezo zindlela zokuphendula, empeleni, ubufakazi obucacile bokuthi yisikhathi sokuba udokotela omusha.
Uma usebenza noDokotela B, kahle, ungase ufune ukubuza ukuthi isiphi isizathu sakhe sokungahlali ukhululekile ngokungeza i- T3 ekwelapheni kwe-levothyroxine kuphela. Lapha, ungase uthande ukukhuluma, noma ngisho nokuletha kabusha noma ikhophi, isifundo seDanish esakhishwa ngasekupheleni kuka-2009 ku- European Journal of Endocrinology . Lokho kuhlola kwakubheka inkinga yokuphikisana enokwenziwa ngokwenziwa komkhiqizo we-T3 njengokwesezela ku-T4-kuphela (levothyroxine) ukwelashwa kwe-hypothyroidism .
Ucwaningo lubike ukuthi amaphesenti angu-49 weziguli afundela ukukhetha ukwelashwa okuhlanganisa i-levothyroxine kanye nomuthi we-T3 , futhi kuphela u-15% okhethwe ukwelashwa kuphela kwe-levothyroxine. (Bheka ngezansi ukuthola ulwazi oluthe xaxa kulolu cwaningo, nokuthi ungathola kanjani ikhophi ukubonisa udokotela wakho.) Uma uDokotela B ehlala engafuni ukuxoxa nge-T3 nawe futhi akakwazi ukukugculisa ngencazelo enengqondo, sekuyisikhathi esisha udokotela we-thyroid .
Uma usebenzisana noDokotela C, zicabange njengenhlanhla. Buza udokotela lokho okushiwo yi-Free T3. Futhi uqhubeke uthola ukuhlolwa kwe-T3 mahhala, uhlale ukhumbule ukuthi ochwepheshe abaningi be-thyroid bakholelwa ukuthi iziguli zizwa ngcono uma amazinga e- T3 mahhala engxenyeni ephezulu yohlu evamile, ngisho naku-75th percentile nangaphezulu kwebanga.
(Isebenza kanjani lokhu? Masenze izibalo.) Uma ibanga lokubhekisela lebhu ye-Free T3 lingu-2.0-4.4 pg / mL, i-midpoint iphakathi kwayo, noma i-3.2, ne-75th percentile yi-3.8.)
Futhi uma uyiguli kaDokotela, futhi, zicabange njengenhlanhla yokuba nodokotela ovulekile futhi owaziyo.
Ngokuqondene nokuphikisana, odokotela bahlale beqaphele ukusebenzisa i-T3 kunoma ubani onomlando wezinhliziyo zenhliziyo noma izinkinga zenhliziyo, nakubantu asebekhulile, ngakho odokotela be-T3-savvy bazogcina lokhu engqondweni.
Inothi kusuka
Uma udinga ukwabelana ngolwazi nodokotela wakho mayelana no-2009 IsiDanishi isifundo, nansi ezinye izinsiza:
- Isihloko: Ucwaningo lubonisa ukuthi Ukwengezwa kwe-T3 kuphezulu kune-Levothyroxine / T4-Kuphela kwelashwa ye-Thyroid ye-Hypothyroidism
- Izikhombo zesifundo sesiDanish: uBirte Nygaard, u-Ebbe Winther Jensen, uJan Kvetny, u-Anne Jarløv noJens Faber. "Imiphumela ye-combination ofrapy ne thyroxine (T4) ne-3,5,3'-triiodothyronine ne-T4 monotherapy ezigulini ezine-hypothyroidism, i-double-blind, i-randomzed cross-over," i- European Journal of Endocrinology, Vol 161, Issue 6, 895-902, Disemba 2009
- Isifundo: Funda i-Abstract / Thola i-Reprint (Ungakhohlwa ukuthi esikhundleni sokukhokha ku-intanethi ukuze uphinde uphinde uphinde uphinde ubhale, ungase ukwazi ukuthola ikhophi yamahhala wephephabhuku wezokwelapha uma unesikole sezokwelapha, umtapo wesibhedlela noma wesayensi eseduze )
> Umthombo:
> Nygaard, B et. al. "Imiphumela ye-combination ofrapy ne thyroxine (T4) ne-3,5,3'-triiodothyronine ne-T4 monotherapy ezigulini ezine-hypothyroidism, i-double-blind, i-randomzed cross-over," i- European Journal of Endocrinology, Vol 161, Issue 6, 895-902, Disemba 2009